Skip to Content
Merck

Skip To

14-515

MAP Kinase 1/Erk1 Protein, inactive, 50 g

Unactive, N-terminal GST-tagged, recombinant, full-length, human MAP Kinase 1/Erk1, for use in Kinase Assays.

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View
Pack SizeSKUAvailabilityPrice
50 μg

Estimated to ship onMay 15, 2026fromAreál Kühne+Nagel spol. s r.o.

CZK 14,300.00

About This Item

UNSPSC Code:
12352202
NACRES:
NA.32
eCl@ss:
32160405
Biological source:
human
Recombinant:
expressed in E. coli

CZK 14,300.00


Estimated to ship onMay 15, 2026Details


Request a Bulk Order
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


biological source

human

Quality Level

recombinant

expressed in E. coli

mol wt

Mw 70 kDa

manufacturer/tradename

Upstate®

technique(s)

activity assay: suitable (kinase)

NCBI accession no.

UniProt accession no.

shipped in

dry ice

General description

N-terminal GST-tagged, recombinant, full-length, human MAP Kinase 1/Erk1
Product Source: expressed in E. coli

Application

Research Category
Metabolism
Research Sub Category
Obesity

Metabolic Disorders

Biochem/physiol Actions

Protein Target: MAPK1
Target Sub-Family: CMGC

Physical form

Glutathione-agarose

Preparation Note

6 months at -20°C

Analysis Note

routinely evaluated by phosphorylation of MBP substrate in vitro

Other Notes

For Specific Activity data, refer to the Certificate of Analysis for individual lots of this enzyme.

Legal Information

UPSTATE is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Compare Similar Items

View Full Comparison

Show Differences

1 of 1

This Item
14-53614-19814-439-M
biological source

human

biological source

human

biological source

mouse

biological source

human

technique(s)

activity assay: suitable (kinase)

technique(s)

activity assay: suitable (kinase)

technique(s)

activity assay: suitable (kinase)

technique(s)

activity assay: suitable (kinase)

recombinant

expressed in E. coli

recombinant

expressed in E. coli

recombinant

expressed in E. coli

recombinant

expressed in E. coli

shipped in

dry ice

shipped in

dry ice

shipped in

dry ice

shipped in

-

UniProt accession no.

P28482

UniProt accession no.

P28482

UniProt accession no.

P63085

UniProt accession no.

P28482

mol wt

Mw 70 kDa

mol wt

Mw 67.8 kDa

mol wt

Mw 67.8 kDa

mol wt

Mw 69.9 kDa


pictograms

Exclamation mark

signalword

Warning

hcodes

Hazard Classifications

Skin Sens. 1

Storage Class

10 - Combustible liquids

wgk

WGK 2



Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



Ivana Yen et al.
Cancer cell, 34(4), 611-625 (2018-10-10)
Targeting KRAS mutant tumors through inhibition of individual downstream pathways has had limited clinical success. Here we report that RAF inhibitors exhibit little efficacy in KRAS mutant tumors. In combination drug screens, MEK and PI3K inhibitors synergized with pan-RAF inhibitors



Global Trade Item Number

SKUGTIN
14-51504053252731983

Questions

Reviews

No rating value

Active Filters